| scholarly article | Q13442814 |
| P2093 | author name string | Wei Wu | |
| David A Johnson | |||
| Wen Y Chen | |||
| Barbara K Vonderhaar | |||
| Ameae M Walker | |||
| Dunyong Tan | |||
| Lingfang Zeng | |||
| Yen Hao Chen | |||
| P433 | issue | 5 | |
| P921 | main subject | bioluminescence | Q179924 |
| P304 | page(s) | 1291-1303 | |
| P577 | publication date | 2005-02-03 | |
| P1433 | published in | Molecular Endocrinology | Q3319475 |
| P1476 | title | Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo- and hetero-pairs of long and short human PRL receptors in living human cells | |
| P478 | volume | 19 |
| Q37649280 | An N-terminal splice variant of human Stat5a that interacts with different transcription factors is the dominant form expressed in invasive ductal carcinoma |
| Q34437651 | Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies |
| Q36615933 | Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia? |
| Q34118514 | Effects of prolactin on TSC2-null Eker rat cells and in pulmonary lymphangioleiomyomatosis |
| Q40828550 | Frontiers commentary on tallet et Al. Investigation of prolactin receptor activation and blockade using time-resolved fluorescence resonance energy transfer |
| Q35971094 | Investigation of prolactin receptor activation and blockade using time-resolved fluorescence resonance energy transfer |
| Q38706936 | Involvement of miR-106b in tumorigenic actions of both prolactin and estradiol |
| Q39801736 | Long term increased expression of the short form 1b prolactin receptor in PC-3 human prostate cancer cells decreases cell growth and migration, and causes multiple changes in gene expression consistent with reduced invasive capacity |
| Q27008904 | Molecular mechanisms of prolactin and its receptor |
| Q37064929 | Paradigm-shifters: phosphorylated prolactin and short prolactin receptors |
| Q37064937 | Rational design of competitive prolactin/growth hormone receptor antagonists |
| Q37060370 | Regulation of prolactin receptor levels and activity in breast cancer |
| Q38785779 | S2 deletion variants of human PRL receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain |
| Q37972125 | Triennial Lactation Symposium: Prolactin: The multifaceted potentiator of mammary growth and function |
| Q34451140 | Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists |
| Q46587394 | Variation in the coding and 3' untranslated regions of the porcine prolactin receptor short form modifies protein expression and function |
Search more.